Background illustration for clinical trials search

Paid Clinical Trials Worcester

Discover 3,097 paid clinical trials in Worcester, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

for
KRAS Altered Advanced or Metastatic Solid Tumors
Location: Boston MA, Philadelphia PA, Montreal, Fairfax VA,
Sponsor: Amgen

Sex: All

Age: 18+

Code: NCT07094113

Phase1, Recruiting

Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter

for
Acute Ischemic Stroke From Large Vessel Occlusion
Location: Boston MA, New York NY, Buffalo NY, Pittsburgh PA,
Sponsor: Anaconda Biomed S.L.

Sex: All

Age: 22 - 70+

Code: NCT06370182

Recruiting

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

for
Advanced Solid Tumor
Location: Boston MA, Hartford CT, New Haven CT, New York NY,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT07070232

Phase1, Phase2, Recruiting

ELEVATE-HFpEF Clinical Study

for
Heart Failure With Preserved Ejection Fraction (HFpEF)
Location: Boston MA, Hartford CT, Burlington VT, Wynnewood PA,
Sponsor: Medtronic Cardiac Rhythm and Heart Failure

Sex: All

Age: 40+

Code: NCT06678841

Recruiting

A Study of PHN-012 in Patients With Advanced Solid Tumors

for
Colon Cancer, Pancreatic Cancer, Lung Cancer (NSCLC),
Location: Boston MA, Washington D.C. DC, Fairfax VA, Durham NC,
Sponsor: Pheon Therapeutics

Sex: All

Age: 18+

Code: NCT07127874

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)

for
Heterozygous Familial Hypercholesterolemia (HeFH)
Location: Boston MA, Wilmington DE, Washington D.C. DC,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 6 - 17

Code: NCT07058077

Phase2, Phase3, Recruiting

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia
Location: Boston MA, South Portland ME, Portland ME,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 65+

Code: NCT07321652

Phase3, Recruiting

Randomization of Single vs Multiple Arterial Grafts

for
Coronary Artery Disease, Heart Diseases
Location: Springfield MA, New York NY, Brooklyn NY, Quebec,
Sponsor: Weill Medical College of Cornell University

Sex: All

Age: 18 - 70

Code: NCT03217006

Recruiting

Ph 2 Elacestrant in ER Positive Uterine Sarcomas

for
Uterine Sarcoma, Uterine Leiomyosarcoma,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: Female

Age: 18+

Code: NCT07467772

Phase2, Recruiting

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

for
Desmoplastic Small Round Cell Tumor, Osteosarcoma,
Location: Boston MA, New York NY, Philadelphia PA, Baltimore MD,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12 - 39

Code: NCT04616560

Phase2, Recruiting

Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)

for
Pulmonary Arterial Hypertension (PAH)
Location: Boston MA, Cincinnati OH, Omaha NE, Aurora CO
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07318597

Phase2, Recruiting

Bowel Continence Across the Lifespan in People With Spina Bifida

for
Spina Bifida, Neurogenic Bowel, Bowel Incontinence
Location: Boston MA, Philadelphia PA, Pittsburgh PA, Durham NC,
Sponsor: David Chu

Sex: All

Age: 5+

Code: NCT07390318

Recruiting

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

for
Malignant Neoplasm
Location: Boston MA, Valhalla NY, New York NY, New Brunswick NJ,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 17

Code: NCT07630974

Phase1, Phase2, Recruiting

A Phase 1 Study of Vaccination With Dendritic Cell (DC)/Multiple Myeloma (MM) Fusions in Combination With Elranatamab in Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma, Relapse Multiple Myeloma,
Location: Boston MA
Sponsor: David Avigan

Sex: All

Age: 18+

Code: NCT06799026

Phase1, Recruiting

A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation

for
AML, MDS
Location: Boston MA, New Haven CT, New York NY, Hackensack NJ,
Sponsor: TScan Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07702578

Phase3, Recruiting

A Ketamine-assisted Group Therapy Intervention for Spanish-speaking Adults With Depression

for
Depression
Location: Chelsea MA
Sponsor: Juliana Zambrano, MD, MPH

Sex: All

Age: 18 - 64

Code: NCT06597695

Phase1, Phase2, Recruiting

Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Juxtarenal Aortic Aneurysms

for
Technical Sucess,
Location: Springfield MA
Sponsor: Baystate Medical Center

Sex: All

Age: 18+

Code: NCT07019454

Recruiting

Practical Geriatric Assessment in Older Adults With Non-Small Cell Lung Cancer Undergoing Stereotactic Body Radiation Therapy

for
Lung Cancer (NSCLC), Geriatric Assessment,
Location: Boston MA
Sponsor: Brigham and Women's Hospital

Sex: All

Age: 65+

Code: NCT06987890

Recruiting

Childhood Cancer Survivor Study

for
Cancer
Location: Boston MA, New York NY, Philadelphia PA,
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0+

Code: NCT01120353

Recruiting

Selinexor and Backbone Treatments of Multiple Myeloma Patients

for
Multiple Myeloma
Location: Boston MA, Durham NC, Seattle WA
Sponsor: Karyopharm Therapeutics Inc

Sex: All

Age: 18+

Code: NCT02343042

Phase1, Phase2, Recruiting